The estimated Net Worth of Jacques Gutedel is at least $1 Million dollars as of 9 August 2016. Jacques Gutedel owns over 4,000 units of LivaNova PLC stock worth over $519,483 and over the last 9 years Jacques sold LIVN stock worth over $484,160.
Jacques has made over 2 trades of the LivaNova PLC stock since 2016, according to the Form 4 filled with the SEC. Most recently Jacques sold 4,000 units of LIVN stock worth $242,080 on 9 August 2016.
The largest trade Jacques's ever made was selling 4,000 units of LivaNova PLC stock on 9 August 2016 worth over $242,080. On average, Jacques trades about 1,333 units every 0 days since 2016. As of 9 August 2016 Jacques still owns at least 10,948 units of LivaNova PLC stock.
You can see the complete history of Jacques Gutedel stock trades at the bottom of the page.
Jacques's mailing address filed with the SEC is 5 MERCHANT SQUARE, NORTH WHARF ROAD, LONDON, X0, W2 1AY.
Over the last 9 years, insiders at LivaNova PLC have traded over $79,802,010 worth of LivaNova PLC stock and bought 4,000 units worth $268,530 . The most active insiders traders include William A Kozy, Two S.C.A.Tower 6 S. A R.L...., and Peter M Wilver. On average, LivaNova PLC executives and independent directors trade stock every 10 days with the average trade being worth of $315,922. The most recent stock trade was executed by Peter M Wilver on 15 June 2024, trading 2,680 units of LIVN stock currently worth $127,166.
livanova plc is a global medical technology company built on nearly five decades of experience and a relentless commitment to improve the lives of patients around the world. our advanced technologies and breakthrough treatments provide meaningful solutions for the benefit of patients, healthcare professionals and healthcare systems.at livanova, we understand the importance of bringing both clinical and economic value to our customers. we are a strong, market-leading medical technology and services company, offering a diverse product portfolio and global reach. livanova is listed on the nasdaq stock exchange under the ticker symbol “livn.” livanova has approximately 3,000 employees worldwide. we are headquartered in london (uk) and maintain a presence in more than 100 countries. livanova is a worldwide leader in advanced circulatory support, cardiopulmonary and neuromodulation, dedicated to creating meaningful products and therapies that transform lives each and every day.
LivaNova PLC executives and other stock owners filed with the SEC include: